Font:
LA

LALPATHLAB / NSE / Healthcare Facilities

Dr. Lal PathLabs

INR 1,691.9-1.10 (0.35%) 1D
Last updated: 2026-07-13T06:14:12.203027+00:00
Price Chart

1Y Price Trend

Open1,455
High1,803
Low1,272.6
Close1,736.1
Volume1,50,163
Change281.1
Change %19.32%

Key Information

Ticker SymbolLALPATHLAB
Current Price1,691.9
52-Week High1,803
52-Week Low1,272.6
Market Cap28,374.02
Beta0.88
Volume1,50,163
ISININE600L01024
Day High1,738
Day Low1,672.5
Open1,692

Recommendations

RatingBuy

Target High1,803.6

Target Low1,272

Target Mean1.92

Target Median15

Risk Metrics

Overall RiskBalanced risk

Board Risk31.51

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Dr Lal Pathlabs Ltd is Rated Hold by MarketsMOJO - Markets Mojo1 month ago
Market news

Dr Lal Pathlabs Ltd is Rated Hold by MarketsMOJO Markets Mojo

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo1 month ago
Market news

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals Markets Mojo

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo1 month ago
Market news

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo

Dr. Lal PathLabs Schedules Analyst and Institutional Investor Meeting on May 20, 2026 - scanx.trade1 month ago
Market news

Dr. Lal PathLabs Schedules Analyst and Institutional Investor Meeting on May 20, 2026 scanx.trade

Dr. Lal PathLabs FY26 Audited Results: Revenue Up 12.2%, Dubai Subsidiary Approved - scanx.trade2 months ago
Market news

Dr. Lal PathLabs FY26 Audited Results: Revenue Up 12.2%, Dubai Subsidiary Approved scanx.trade

Dr Lal PathLab Standalone March 2026 Net Sales at Rs 675.20 crore, up 16.98% Y-o-Y - Moneycontrol.com2 months ago
Market news

Dr Lal PathLab Standalone March 2026 Net Sales at Rs 675.20 crore, up 16.98% Y-o-Y Moneycontrol.com

Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing - The Economic Times2 months ago
Market news

Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing The Economic Times

Dr Lal PathLabs hits 20% upper band on strong Q4; brokerages stay positive - Business Standard2 months ago
Market news

Dr Lal PathLabs hits 20% upper band on strong Q4; brokerages stay positive Business Standard

FAQ

Stock FAQs

What is the symbol and ISIN of Dr. Lal PathLabs?

Dr. Lal PathLabs has the symbol LALPATHLAB and ISIN - INE600L01024.

What is the current price of Dr. Lal PathLabs?

Dr. Lal PathLabs is currently trading at INR 1,691.90.

What are the year high and year low of Dr. Lal PathLabs?

Dr. Lal PathLabs has a year high of INR 1,803.60 and a year low of INR 1,272.00.

What is the market capitalization of Dr. Lal PathLabs?

Dr. Lal PathLabs has a market capitalization of INR 28,374.02 crore.

What is the P/E ratio of Dr. Lal PathLabs?

Dr. Lal PathLabs has a P/E ratio of 43.31.

What is the dividend yield of Dr. Lal PathLabs?

Dr. Lal PathLabs has a dividend yield of 0.83%.

How is the financial performance of Dr. Lal PathLabs based on revenue, net income, and EPS?

Dr. Lal PathLabs has revenue of INR 27,629.11 crore, net income of INR 5,047.79 crore, and EPS of INR 31.57.

What is the book value of Dr. Lal PathLabs?

Dr. Lal PathLabs has a book value of INR 105.84.

What is the debt-to-equity ratio of Dr. Lal PathLabs?

Dr. Lal PathLabs has a debt-to-equity ratio of NA.

What are the price-to-book and price-to-sales ratios of Dr. Lal PathLabs?

Dr. Lal PathLabs has a price-to-book ratio of 15.99 and a price-to-sales ratio of 1.03.